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Abstract 
 
Mosquitoes transmit a range of pathogens, such as malaria protozoans, dengue, Ross River 
and Barmah Forest viruses. Human infection with any of these pathogens may lead to the 
onset of debilitating disease, and due to limited vaccine availability, mosquito control is 
essential to interrupt the transmission of disease. During control operations, the larvae are 
targeted and there are two classes of biologically-based insecticides available: microbials 
(Bacillus thuringiensis var. israelensis de Barjac [Bti] and Bacillus sphaericus Neide [Bs]) 
and insect growth regulators (s-methoprene and pyriproxyfen). The aims of this thesis were 
to: 1) undertake specific research to enhance mosquito control operations; and 2) evaluate the 
ecological impacts of insecticide use in saltmarsh habitats. 
Initially, the efficacy of new formulations of biologically-based insecticides were investigated 
in the laboratory. Bioassays were conducted using third-instars of six common Australian 
mosquito species, Aedes aegypti (Linnaeus), Aedes vigilax (Skuse), Aedes notoscriptus 
(Skuse), Culex sitiens Wiedemann, Culex annulirostris Skuse and Culex quinquefasciatus 
Say. The normal model for log-linear mortality was used to determine LC50 and LC95 values. 
The newly developed VectoBac WG (3,000 Bti International Toxic Units [ITU]/mg) was 
highly effective against the range of larvae, contrasting with the unregistered insect growth 
regulator, pyriproxyfen, which was not effective against some species.  
Sequentially, the efficacy of Bti formulations was assessed in the field. Larvae were exposed 
to Bti as free-swimming larvae and in mesh cages, and mortality was calculated after 48 h to 
examine appropriate sampling techniques. The accuracy of sampling free-swimming larvae 
with 250-ml ‘dips’ was highly variable, where monitoring mortality of caged larvae was 
highly accurate; this information was used to design the sequential field trials. In freshwater 
pools, replicated cohorts of caged Cx. annulirostris were exposed to the water dispersible 
(VectoBac WG) and liquid (VectoBac 12AS: 1,200 Bti ITU/mg) formulations. Treatment 
concentrations of 0.008 ppm VectoBac WG and 0.04 ppm VectoBac 12AS and above 
produced significant larval control (>96% mortality) at 48 h, with no residual control after 1 
week. In saltmarsh pools, cohorts of caged Ae. vigilax were exposed to the granular 
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(VectoBac G: 200 Bti ITU/mg) formulation; which was effective (>99% mortality) at 
application rates of 4 kg/ha and above at 48 h.  
Next, the distribution of the granular (VectoBac G) formulation was assessed after an aerial 
treatment using catch-trays. The accuracy of the catch-trays was defined using mathematical 
models. Specifically, the analysis revealed that the size of catch-trays can affect the 
interpretation of results, especially if smaller than 2 m2. The mass of product captured in 1 m2
catch-trays, due to random sampling processes alone, would be expected to range between the 
equivalent of 2.9 to 7.8 kg/ha for 95% of replicates when targeting 5 kg/ha. During the field 
trial, 1 m2 catch-trays were used, this catch-tray size was selected as it was the nominated size 
used by contractors for quality assurance of aerial granular applications. The average flight 
lane separation of the rotary-wing aircraft was 14.70 m (SD: ± 4.52 m) and the average 
treatment rate was 5.76 kg/ha (SD: ± 3.46 kg/ha; CV = 60%). This was close to the targeted 
lane separation of 14 m and treatment rate of 5 kg/ha. However, the product was not 
distributed evenly. Nonetheless, there was 100% mortality of third-instar Ae. vigilax that were 
exposed to the treatment in mesh cages. The most important factors that affected the observed 
spatial distribution of product were the uneven flight path of the helicopter and the low 
sensitivity of the small catch-trays.  
Despite the fact that Bti and s-methoprene are considered to be among the most target specific 
of insecticides, there are indications that non-target organisms may be impacted in different 
ecosystems. In response, changes in the density and diversity of non-target communities, after 
application of either Bti or s-methoprene, were examined. The main taxa collected from 
ephemeral pools were Copepoda; and from terrestrial plots were Collembola, Coleoptera, 
Heteroptera, Hymenoptera and Diptera. Applications of both products altered the community 
composition; however, differences were not consistent over the two localities. After 
applications of Bti to ephemeral pools, lower numbers of Copepoda were recorded at only one 
location. No differences were recorded after treatments of s-methoprene to ephemeral pools. 
After applications of s-methoprene to terrestrial plots, higher numbers of Acariformes were 
recorded at both localities, and this was also recorded after application of Bti to one of the 
locations. However, these differences were not spatially and temporally consistent or in 
agreement with predictions. The results of these trials suggest that applications of Bti and s-
methoprene will not impact on the long-term structure and composition of arthropod 
assemblages in saltmarshes. Authors of previous studies from the northern hemisphere had 
vindicated that s-methoprene was more broadly toxic to non-target organisms than Bti;
however, this is not true in Australia. 
The results of this thesis found that Bti can be used to effectively control mosquito immatures 
under different field conditions. Applications of Bti and s-methoprene did not decrease the 
diversity or abundance of non-target arthropods in south-east Queensland. As such, future 
applications of Bti and s-methoprene are supported in preference to organophosphate 
alternatives; this is based on a comparison with previously published literature that has 
demonstrated organophosphate insecticides to be directly toxic to non-target arthropods. 
Considering that the appropriate use of Bti and s-methoprene can reduce the incidence of 
arbovirus transmission among the local human population, the future application of these 
products is supported. The use of insecticides should be integrated with public education, 
biological control, physical habitat modification and early detection systems. 
 

vii 
 
Acknowledgements 
I thank my supervisors, Prof. Brian Kay (Queensland Institute of Medical Research [QIMR]) 
and Assoc. Prof. Greg Skilleter (Integrative Biology, The University of Queensland) for their 
continual commitment, guidance and suggestions throughout all stages of the project. I thank 
my colleagues at the Mosquito Control Laboratory for their friendship and support, 
particularly: Mark Breitfuss, for support and guidance especially in the early stages of the 
project; Kay Marshall, who provided technical support throughout many stages of the project; 
Michelle Gatton, for providing detailed statistical advice and Peter Ryan, who provided 
statistical advice and general support during all stages of the project. I would like to thank my 
family, friends and flatmates for their ongoing support and encouragement over the years. In 
particular, my partner Dale Young: your belief in my abilities has allowed me to achieve more 
than I ever thought possible. 
This work was primarily funded by an Australian Postgraduate Award. Additional funding 
was provided by the Mosquito and Arbovirus Research Committee Inc., particularly Redland 
Shire Council, whom I anticipate will obtain practical benefits from the findings within this 
thesis. Further funding was provided by a Queensland Health Arbovirus Prevention Grant, 
Valent Biosciences and Sumitomo Chemicals. In addition, I would like to thank QIMR for the 
use of facilities and resources.  
Chapter 2. I thank Valent Biosciences for supplying Bacillus thuringiensis var. israelensis 
and Sumitomo Chemicals Co. for supplying pyriproxyfen.  
Chapter 3. I wish to thank Redcliffe City council, particularly Michael Asnicar, and his staff 
for support. Thanks to PURAC waste water treatment plant and Leaf Liaisons for permission 
to conduct field trials on their property. For assistance with field work, I thank Darren 
Alsemgeest, George Santagiuliana and Scott Dunsdon, Redland Shire Council, as well as 
Scott Lyons, QIMR. I would also like to thank George Santagiuliana for his continued 
technical support and advice at all stages of the project.  
viii 
 
Chapter 4. For assistance with field work, I would like to thank Scott Lyons and Tim Hurst 
(QIMR) and the technical staff of Redland Shire Council, especially George Santagiuliana 
and Scott Dunsdon. Additionally, Robert Fusco from Valent Biosciences and Doug Paton and 
Patrick Press from Sumitomo Chemicals provided field assistance and technical support 
throughout the project. The catch-trays were supplied by Nicholas Woods and Murray Burns 
at the Centre for Pesticide Application and Safety, The University of Queensland, who also 
weighed and counted the product captured in the catch-trays.   
Chapter 5. Thanks go to Gold Coast City, Redlands Shire and Pine Rivers Shire Councils for 
support and the provision of field sites. Many thanks to Jason Jeffery, Tim Hurst, Anna 
Guerney (QIMR) and particularly Scott Lyons (QIMR) and Nadia Aurisch (UQ) who spent 
many hours in the field, assisting with the collection of samples.  
ix 
 
Table of contents 
Declaration i
Abstract iii 
Acknowledgements vii 
Table of contents ix 
List of tables xiii 
List of figures xvii 
List of abbreviations xxi 
List of publications relevant to thesis xxv 
Problem definition and thesis outline xxvii 
Chapter 1  Literature review 1 
 1.1  Introduction 1 
 1.2  Mosquito-borne disease in Australia 2 
 1.3  Habitats of mosquito larvae 5 
 1.3.1  Freshwater 6 
 1.3.2  Saltmarshes and mangroves 7 
 1.4  Early mosquito control efforts 8 
 1.5  Microbial insecticides 11 
 1.5.1  Bacillus thuringiensis var. israelensis 12 
 1.5.2  Bacillus sphaericus 18 
 1.6  Insect growth regulators 19 
 1.6.1 s-methoprene 22 
 1.6.2 Pyriproxyfen 26 
 1.7  Ecological impacts of biologically-based larvicides 28 
 1.7.1 Bacillus thuringiensis var. israelensis 28 
 1.7.2 s-methoprene 37 
 1.8  Conclusions 46  
xChapter 2  Laboratory susceptibility of mosquito larvae to new biologically- 49
based insecticides 
2.1  Introduction 49 
 2.2  Methods 51 
 2.2.1  Laboratory bioassays 51 
 2.2.2  Environmental influences 55 
 2.2.5  Statistical methods 56 
 2.3  Results 58 
 2.3.1  Laboratory bioassays 58 
 2.3.2  Environmental influences 64 
 2.4  Discussion 68 
Chapter 3  Efficacy of Bacillus thuringiensis var. israelensis to control mosquito 71
larvae under field conditions 
 3.1  Introduction 71 
 3.2  Methods 74 
 3.2.1 Development of appropriate sampling techniques 74 
 3.2.2 Efficacy of Bti in the field 77 
 3.2.3 Statistical methods 78 
 3.3  Results 80 
 3.3.1 Development of appropriate sampling techniques 80 
 3.3.2 Efficacy of Bti in the field 83 
 3.4  Discussion 89 
 3.4.1 Development of appropriate sampling techniques 89 
 3.4.2 Efficacy of Bti in the field 90 
Chapter 4  Spatial distribution of aerially applied granular Bacillus thuringiensis 93
var. israelensis (VectoBac G) 
4.1  Introduction 93 
 4.2  Methods 96 
 4.2.1 Modelling product distribution 96 
 4.2.2 Aerial trials 97 
 4.2.3 Statistical methods 99 
 
Table of contents    xi 
 
4.3  Results 102 
 4.3.1 Modelling product distribution  102 
 4.3.2 Aerial trials 113 
 4.4  Discussion 121 
Chapter 5  Evaluation of potential ecological impacts of Bacillus israelensis var.  125
thuringiensis and s-methoprene on non-target organisms of saltmarsh  
 and mangrove habitats 
 5.1  Introduction 125 
 5.2  Methods 127 
 5.2.1 Study area 127 
 5.2.2 Experimental design 129 
 5.2.3 Development of appropriate sampling techniques 129 
 5.2.4 Selection of experimental plots 135 
 5.2.5 Sampling technique 136 
 5.2.6 Statistical methods 137 
 5.3  Results 139 
 5.3.1 Development of appropriate sampling techniques 139 
 5.3.2 Impacts of Bti and s-methoprene 141 
 5.4  Discussion 152 
Chapter 6  Concluding discussion 157
6.1  Assessing the use of new insecticides 157 
 6.2  Contribution to mosquito control operations 159 
 6.3  Insecticides as part of an integrated pest management plan for  162 
 mosquito control 
 6.4  Mosquito control in perspective 164 
 6.5  Conclusions 165 
List of references  167
Appendix A   Publications relevant to thesis 213
Appendix B Toxicity of three insecticides to the commercial prawns 245
Penaeus japonicus and Penaeus monodon 

xiii 
 
List of tables 
 
Table 1.1 The larval habitats and distribution of Australian mosquitoes and the 
associated human diseases. 
3
Table 1.2 Efficacy of Bacillus thuringiensis var. israelensis for the control of 
mosquito larvae.  
14
Table 1.3 The formulations of Bacillus thuringiensis var. israelensis registered for 
mosquito control in Australia.  
16
Table 1.4 Efficacy of Bacillus sphaericus for the control of mosquito larvae.  20
Table 1.5 Efficacy of s-methoprene for the control of mosquito larvae.  23
Table 1.6 The formulations of s-methoprene registered for mosquito control in 
Australia.  
25
Table 1.7 Efficacy of pyriproxyfen for the control of mosquito larvae.  27
Table 1.8 The impacts of Bacillus thuringiensis var. israelensis on non-target 
organisms.  
30
Table 1.9 The impacts of s-methoprene on non-target organisms.  38
Table 2.1   Laboratory susceptibility of mosquito larvae to VectoBac WG (3,000 Bti 
ITU/mg) after 48 h exposure.  
59
Table 2.2   Laboratory susceptibility of mosquito larvae to technical grade 
pyriproxyfen. 
61
Table 3. 1  Label rates of three Bacillus thuringiensis var. israelensis formulations 
(VectoBac) for application against mosquito larvae in Australia and the 
USA. 
73
xiv 
 
Table 3.2 Abbott’s adjusted per cent control of third-instar Aedes vigilax exposed to 
VectoBac G (200 Bti ITU/mg) at various treatment rates for 48 h. 
82
Table 3.3 Abbott’s adjusted per cent control of caged third-instar Culex 
annulirostris exposed to VectoBac WG (3,000 Bti ITU/mg) and VectoBac 
12AS (1,200 Bti ITU/mg) at various treatment rates for 48 h. 
84
Table 3.4   Abbott’s adjusted per cent control of caged third-instar Aedes vigilax 
exposed to VectoBac G (200 Bti ITUs/mg) at various treatment rates after 
48 h. 
87
Table 4.1 The 95% bounds calculated for the expected number of particles per 
catch-tray of different sizes for Altosid pellets (40 g AI/kg), VectoBac G 
(200 Bti ITU/mg) and Altosand (4 g AI/kg). 
103
Table 4.2 The width of the theoretical 95% bounds for the treatment rate (kg/ha) 
calculated from the simulated weight per catch-tray, in trays of different 
sizes for Altosid pellets (40 g AI/kg), VectoBac G (200 Bti ITU/mg) and 
Altosand (4 g AI/kg). 
105
Table 4.3 The number of catch-trays required to evaluate an aerial application of 
Altosid pellets (40 g AI/kg), VectoBac G (200 Bti ITU/mg) and Altosand 
(4 g AI/kg) in catch-trays of different sizes to achieve an estimate of the 
mean with ± 5% accuracy. 
112
Table 4.4 Moran’s I spatial autocorrelation indices for weights of VectoBac G 
collected in catch-trays after the aerial treatment in March 2003 
117
Table 5.1   The non-target organisms previously recorded in subtropical saltmarshes 
in Moreton Bay, south-east Queensland. 
130
Table 5.2 The experimental treatments of Bti and s-methoprene that were conducted 
in three locations in Moreton Bay to examine the impacts on non-target 
arthropods sampled from terrestrial and aquatic plots in the saltmarsh. 
132
List of tables    xv 
 
Table 5.3 Mean (± SD) total number of individuals collected from terrestrial and 
aquatic plots, after treated plots were exposed to Bti. The percent 
reduction of individuals in treated pools is highlighted, but there was no 
statistical difference between treated and control means (ANOVA: p >
0.05). 
140
Table 5.4 Differences in community composition between treated (Bti and s-
methoprene) and control plots, compared with non-parametric 
multivariate analysis of variance (using PERMANOVA). 
142
Table 5.5 Differences in abundance of individual taxa between treated (Bti and s-
methoprene) and control plots, compared with univariate two-way 
analysis of variance (using STATISTICA). 
146

xvii 
 
List of figures 
 
Figure 1.1 Insecticide use for mosquito control between 1984 and 2005 in south-
east Queensland by CLAG members (Gold Coast City Council, 
Redlands Shire Council, Logan City Council and Tweed Shire Council; 
information collated from CLAG quarterly reports 1984 – 2005). 
 
10
Figure 2.1    Static exposure bioassays were conducted in replicate glass beakers each 
containing 20 test larvae.  
53
Figure 2.2    Mean mortality (± 95%) of third-instars exposed to VectoBac WG 
(3,000 Bti ITU/mg) for 48 h in the laboratory. 
60
Figure 2.3    Mean emergence inhibition (± 95%) of mosquito larvae exposed to 
technical grade pyriproxyfen in the laboratory. 
62
Figure 2.4    Mean (± SD) percent mortality of third-instar Aedes notoscriptus 
exposed to VectoBac products (G: 200 Bti ITU/mg; WG: 3,000 Bti 
ITU/mg; 12AS: 1,200 Bti ITU/mg); a) with and b) without the presence 
of sunlight. 
65
Figure 2.5    Mean (± SD) percent mortality of third-instar Aedes aegypti exposed to 
VectoBac G (200 Bti ITU/mg); a) with and b) without the presence of 
soil. 
67
Figure 3.1 Map of Queensland and the Moreton Bay region in south-east 
Queensland (Lat. 27ºS, Long. 153ºE) showing the locations used to 
examine the efficacy of Bti in the field. 
75
Figure 3.2 Schematic of experimental design used to compare the sampling 
techniques of cages and dips used to sample third-instar Aedes vigilax.
76
xviii 
 
Figure 3.3 Mean (± SD) number of Aedes vigilax sampled at 48 h post-treatment 
from a) cages and b) 10 replicate 250 ml dips of free-swimming larvae. 
81
Figure 3.4 Field evaluation of a) VectoBac WG (3,000 Bti ITU/mg) and b) 
VectoBac 12AS (1,200 Bti ITU/mg) efficacy against Culex annulirostris 
after 48 h. 
85
Figure 3.5    Field efficacy (mean mortality ± SD) of various VectoBac G (200 Bti 
ITU/mg) treatments against caged Aedes vigilax in saltmarsh pools after 
48 h.  
88
Figure 4.1    VectoBac G (200 Bti ITU/mg) was distributed with rotary-wing aircraft, 
fitted with specially designed hoppers for product dispersal.  
98
Figure 4.2 The cumulative frequency Poisson distribution of the expected number 
of particles of Altosid pellets (40g AI/kg; 2 – 5 kg/ha), VectoBac G (200 
Bti ITU/mg; 4 – 8 kg/ha) and Altosand (4g AI/kg; 2 – 6 kg/ha) in 
different sized catch-trays at different treatment rates. 
104
Figure 4.3    The theoretical distribution of the mass of VectoBac G (200 Bti 
ITU/mg) in 1 and 2 m2 catch-trays at different treatment rates (4, 5, 6, 7 
and 8 kg/ha).  
106
Figure 4.4    The theoretical distribution of the mass of Altosid pellets (40g AI/kg) in 
1 and 4 m2 catch-trays at different treatment rates (2, 3, 4 and 5 kg/ha). 
107
Figure 4.5    The theoretical distribution of Altosand (4g AI/kg) in 1 m2 catch-trays at 
different treatment rates (2, 3, 4, 5 and 6 kg/ha). 
108
Figure 4.6   The theoretical bounds of product distribution for a) Altosid pellets (40 g 
AI/kg) at 4 kg/ha, b) VectoBac G (200 Bti ITU/mg) at 5 kg/ha and c) 
Altosand (4 g AI/kg) at 4 kg/ha, calculated from the simulated mass 
captured in catch-trays of different sizes. 
109
List of figures    xix 
 
Figure 4.7 The 95% confidence intervals surrounding the mean application rate 
(kg/ha) calculated from 100 simulations for each sample size (n) for a) 
Altosid pellets (40 g AI/kg) at 4 kg/ha, b) VectoBac G (200 Bti ITU/mg) 
at 5 kg/ha and c) Altosand (4 g AI/kg) at 4 kg/ha. 
111
Figure 4.8    The cumulative frequency distribution of VectoBac G (200 Bti ITU/mg) 
particles captured in 1 m2 catch-trays, in the saltmarsh, after the aerial 
treatment in March 2003 (n = 26), compared with the Poisson 
distribution expected with treating at 5 and 7 kg/ha (see Figure 4.2). 
114
Figure 4.9    The distribution of VectoBac G (200 Bti ITU/mg) captured in 1 m2
catch-trays, in the saltmarsh, after the aerial treatment in March 2003 (n
= 26), compared with the theoretical distribution of expected mass at a) 
5 kg/ha and b) 7 kg/ha (see Figure 4.3).  
115
Figure 4.10 Position of bioassay cages, catch-trays and helicopter flight path that a) 
is overlaid on an aerial photograph of Redlands Shire Council, and b) 
displays the weights of VectoBac G (200 Bti ITU/mg) captured in each 
catch-tray after the treatment in March 2003. 
116
Figure 4.11 Weight (g) of VectoBac G (200 Bti ITU/mg) captured per catch-tray 
compared with the distance to the nearest flight path (m) after the aerial 
treatment in March 2003 targeting 5 kg/ha. 
120
Figure 5.1 Map of Queensland and the Moreton Bay region in south-east 
Queensland (Lat. 27ºS, Long. 153ºE) showing the locations used to 
examine the effects of Bti and s-methoprene on non-target organisms. 
128
Figure 5.2 nMDS ordinations on fourth-root transformed species abundance data 
based on the Bray-Curtis similarity measure from replicate samples from 
Bti treated and control plots.  
143
Figure 5.3 Mean (± SD) abundance of Acariformes from treated and control plots 
sampled after treated plots were exposed to either Bti or s-methoprene. 
145
xx 
 
Figure 5.4 Mean (± SD) abundance of Collembola from treated and control plots 
sampled in pit-fall traps after treated plots were exposed to either Bti or
s-methoprene. 
149
Figure 5.5 Mean (± SD) abundance of Copepoda from treated and control plots 
after treated plots were exposed to either Bti or s-methoprene. 
150
Figure 6.1    Proposed process for investigating the possibility of incorporating new 
insecticide formulations into current control operations 
158
xxi 
 
List of abbreviations 
 
% Percentage 
> Greater than 
< Less than 
µm Micrometre 
oC Degrees Celsius 
oS Degrees South 
oE Degrees East 
12AS  1200 Bti ITU/mg in aqueous solution 
Ae.  Aedes 
AI  Active ingredient 
ALL  Altosid Liquid Larvicide 
ANOVA Analysis of variance 
AS  Aqueous solution 
ASAE  American Society of Agricultural Engineers 
BFV  Barmah Forest virus 
Bs  Bacillus sphaericus 
Bt  Bacillus thuringiensis 
Bti  Bacillus thuringiensis var. israelensis 
CL  Confidence limit 
CLAG  Contiguous Local Authorities Group 
cm  Centimetre 
CV  Cumulative variance 
Cx. Culex 
d Day 
DDT  Dichloro-diphenyl-trichloroethane 
DENV  Dengue virus 
dGPS  Differential global positioning system 
dia.  Diameter 
xxii 
 
DNA  Deoxyribonucleic acid 
EFC  Estimated field concentration 
EI50 Concentration resulting in 50 per cent emergence inhibition 
EI95 Concentration resulting in 95 per cent emergence inhibition 
ESRI  Environmental Systems Research Institute 
F F value 
g Grams 
G Granular  
h Hour 
ha  Hectare 
ITU  International toxic units 
JEV  Japanese encephalitis 
KUNV  Kunjin virus 
L Litre 
kg  Kilograms 
LC50 Lethal concentration resulting in 50 per cent mortality 
LC95 Lethal concentration resulting in 95 per cent mortality 
m Metre 
mm  Millimetre 
MARC Mosquito and Arbovirus Research Committee Inc. 
mg  Milligram 
ml  Millilitre 
MVEV Murray Valley encephalitis virus 
n Number 
N North 
NEMMO North East Moreton Mosquito Organisation 
NSW  New South Wales 
NT  Northern Territory 
NTUs  Nephelometric turbidity units 
p p value 
pH  Potential hydrogen 
ppb  Parts per billion 
ppm  Parts per million 
List of abbreviations    xxiii 
 
QIMR  Queensland Institute of Medical Research 
QLD  Queensland 
RRV  Ross River virus 
s Second 
SA  South Australia 
SD  Standard deviation 
SG  Sand granule 
TAS  Tasmania 
ULV  Ultra low volume 
V Volts 
VIC  Victoria 
WA   Western Australia 
WG  Water dispersible granule 
WHO  World Health Organisation 
z PART Number of particles  
 

xxv 
 
List of publications relevant to thesis1
Russell, T. L., M. D. Brown, D. Purdie, P. A. Ryan, and B. H. Kay. 2003. Efficacy of 
VectoBac (Bacillus thuringiensis var. israelensis) formulations for mosquito control in 
Australia. Journal of Economic Entomology 96: 1786-1791. 
Russell, T. L., and B. H. Kay. 2005. The use of Bacillus thuringiensis var. israelensis for the 
control of arbovirus vectors in the Australian environment. Arbovirus Research in 
Australia 9: 337-343 
Russell, T. L., Kay, B. H. and Ryan, P. A. 2005. Mosquito control and Bacillus 
thuringiensis var. israelensis use, an Australian perspective, pp. 57-72. In N. D. Binh, 
R. J. Akhurst and D. Dean [eds.], 5th Pacific Rim conference on the biotechnology of 
Bacillus thuringiensis, Hanoi Vietnam. 
 
1 Attached as Appendix A. 

xxvii 
 
Problem definition and thesis outline 
 
Mosquitoes transmit a range of pathogens, such as malaria protozoans (Knab 1913) and over 
500 arboviruses, including: dengue, Japanese encephalitis, Kunjin, West Nile, Yellow Fever, 
Ross River and Barmah Forest (Kay 1982, Russell and Kay 2004). Human infection with any 
of these pathogens may lead to the onset of debilitating disease, which is potentially lethal, 
except for Ross River and Barmah Forest viruses (Mackenzie et al. 1994, Gubler 1998b, 
Russell and Kay 2004). Currently, vaccines are only available for Japanese encephalitis and 
Yellow Fever, and funding for vaccine development is limited and only available for malaria 
and dengue (Gubler 1998a). Thus, mosquito control is, and will remain, essential to interrupt 
the transmission of disease to humans. 
Even though organised and broad-scale mosquito control programs have been implemented in 
many areas of the globe, there remains a high incidence of disease. The factors influencing 
this are diverse and include changes to water management in or near human communities, 
such as increased water storage for urban or rural use, development of constructed wetlands 
for water management or treatment, and increases in irrigation for agriculture (Russell 2002). 
Increased larval habitat in close proximity to humans may result from growing urbanisation 
with insufficient infrastructure (i.e. water supply and sanitation) and to further complicate 
this, the poverty that is often associated with these communities will impair their ability to 
treat and control the diseases. In addition, rapid international travel has the potential to 
introduce pathogens to areas in which they are currently absent (Gratz 1999). The predicted 
increases in rainfall and temperature from global warming also are likely to extend the 
distribution of mosquitoes and pathogens, as well as shorten the development time of larvae 
and the extrinsic incubation period of pathogens (Russell 1998b, Tanser et al. 2003, 
McMichael et al. 2006). All of the above coupled with a lack of political will and insufficient 
funding, has the potential to increase the incidence of mosquito-borne disease in the future. 
Given this scenario and growing environmental consciousness, there is an ongoing need for 
research into suitable insecticides and delivery methods to serve as a basis for efficacious and 
environmentally-friendly mosquito control. In response, this thesis addresses issues relating to 
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the efficacy and environmental impacts of specific insecticides and makes suggestions for 
improving mosquito control programs, particularly in the Australian context.  
Initially, a review of the existing literature is presented (Chapter 1). Two classes of 
biologically-based insecticides are available for mosquito control: microbials and insect 
growth regulators, which have been used for the global control of mosquitoes for more than 
20 years (Mian and Mulla 1982, Margalit and Dean 1985). The most widely used microbial 
insecticide is Bacillus thuringiensis var. israelensis de Barjac (Bti) and it is regularly used in 
all larval habitats. The use of a second microbial insecticide, Bacillus sphaericus Neide (Bs), 
is limited, as it is only recommended for ground-pool freshwater species (Brown et al. 2004). 
With insect growth regulators, only s-methoprene is registered for mosquito control in 
Australia and it is used to control both freshwater and saltmarsh/mangrove larvae. A second 
insect growth regulator, pyriproxyfen, is undergoing product registration and little is 
understood of its efficacy against Australian mosquito larvae.  
The research component of this thesis consists of four chapters that examine the use of 
biologically-based insecticides for mosquito control and for their possible environmental 
impacts.  
Initially, the efficacy of recently developed formulations of biologically-based insecticides 
(Bti and pyriproxyfen) for mosquito control were examined in the laboratory (Chapter 2). The 
standard method, outlined by the World Health Organisation (see World Health Organisation 
[WHO] 1996), for assessing the laboratory susceptibility of mosquito larvae to insecticides 
was followed. Experiments conducted in the laboratory are relatively inexpensive and simple 
to conduct compared to field trials, but they minimise environmental influences that may 
affect product performance.  
Once the base-line susceptibility of mosquito larvae to an insecticide has been determined in 
the laboratory, the insecticide should be tested in the field, before it is recommended for use 
in routine control programs. As such, the efficacy of various Bti formulations was assessed in 
ground-pool freshwater habitats against Culex annulirostris Skuse and in saltmarsh/mangrove  
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habitats against Aedes vigilax (Skuse)1 (Chapter 3). Larvae were exposed to Bti as free-
swimming larvae and in mesh cages, and mortality was calculated after 48 h. Apart from 
providing essential data on efficacy, this section deals with methodological issues associated 
with larval sampling.  
As broad-scale mosquito control treatments in south-east Queensland are usually conducted 
aerially using rotary-wing aircraft, such treatments are evaluated for efficacy and uniformity 
of distribution (Chapter 4). Traditionally, quality control is evaluated using 1-m2 catch-trays, 
but the precision of such methods has never been investigated. As such, a statistical modelling 
procedure was used to determine the precision of different sized of catch-trays. This was then 
ground-truthed with a field trial where the distribution of granular Bti (VectoBac G) was 
evaluated (at 1 dosage) to determine if VectoBac G was efficacious for the control of Ae. 
vigilax.
Finally, the possible ecological impacts of Bti and s-methoprene application on non-target 
organisms in saltmarshes was assessed (Chapter 5). Despite the fact that Bti and s-methoprene 
are considered to be among the most target-specific of insecticides (e.g. Ali 1981, Mulla et al. 
1982, Brown et al. 2000a), there are indications that non-target organisms may be impacted in 
different ecosystems (e.g. Car and de Moor 1984, Hershey et al. 1998). In particular, the 
results of a long-term field trial by Hershey et al. (1998) contradicted those from many 
laboratory-based toxicological experiments indicating that Bti and s-methoprene may impact 
on non-target insects. This highlighted the need for field-based ecological testing, where local 
fauna undergo natural population changes and population-level interactions. As such, the 
impact of Bti and s-methoprene on non-target invertebrates in subtropical Australian 
saltmarshes was investigated. Changes in the density and diversity of non-target communities 
after experimental applications of Bti or s-methoprene were compared with untreated plots 
over time. The trial was designed to sample the range of aquatic and terrestrial organisms that 
inhabit saltmarshes and are regularly exposed to Bti and s-methoprene applications. From 
January to March 2004, a pilot trial was conducted to evaluate methods for sampling the 
 
1 There is a debate surrounding the appropriate nomenclature of many Aedes species; which was initiated by 
Reinert (2000) and Reinert et al. (2004), and was supported by Black (2004). However, arguments against the 
elevation of subgenus to genus have been made by Savage and Strickman (2004), Savage (2005) and in a Letter 
from the Editor of the Journal of Medical Entomology (2005). For the purposes of this thesis, the original 
mosquito nomenclature has been retained. 
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common non-target organisms, such as Copepoda from ephemeral pools, and Collembola, 
Coleoptera, Heteroptera, Hymenoptera and Diptera from terrestrial plots. Using this 
information, trials were designed and conducted at two localities in Moreton Bay, south-east 
Queensland, from December 2004 to March 2005. 
The main findings and conclusions from the thesis are integrated and discussed in Chapter 6. 
The contribution of this work to the current knowledge of insecticide use and the possible 
environmental impacts of mosquito control are highlighted. Recommendations to increase the 
efficacy of mosquito control operations with minimal environmental harm are suggested. 
